Bioclinica announced that Charles “Chuck” Bodner has joined the company as Executive Vice President, Chief Operating and Financial Officer.
PRINCETON, N.J., Feb. 25, 2020 /PRNewswire/ -- Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announced that Charles “Chuck” Bodner has joined the company as Executive Vice President, Chief Operating and Financial Officer. He will assume responsibility for the company’s business operations, including finance, legal, information technology, human resources and corporate development, as well as strategic oversight of the Drug Safety Solutions business unit.
The company also announced the promotion of Maureen Marchek to the new role of Senior Vice President, Finance, with responsibility for the controller, financial planning, and procurement functions. Marchek has been with the company since 2014 and was previously Corporate Controller.
“I am delighted to join the Bioclinica team and share in their enthusiasm to help bring safe and effective new pharmaceutical products to the marketplace. It’s an exciting time to join the organization and I look forward to the opportunity to help the company continue to grow, while creating sustainable long-term value,” said Bodner.
Most recently at BD (Becton, Dickinson and Company) as Senior Vice President, Chief Accounting Officer, & CFO of International, Bodner brings over two decades of healthcare experience to his new role at Bioclinica. While at BD, he held leadership positions in both corporate and commercial finance, including leadership of value capture activities as part of the CareFusion acquisition. Prior to his time at BD, Bodner held positions of increasing responsibility at Sanofi, Schering-Plough, and AstraZeneca.
“Chuck’s extensive operational and financial management experience will further strengthen our leadership team as we continue to grow into new markets. I am thrilled to welcome him to Bioclinica,” said Euan Menzies, Executive Chairman & CEO. “I would also like to congratulate Maureen on her well-deserved promotion to Senior Vice President.”
About Bioclinica
Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and
budget forecasting; pharmacovigilance, and trial management. The company’s thousands of employees serve more than 500 pharmaceutical, biotechnology and device organizations – including all top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.
Learn more at www.bioclinica.com.
Media Contact
Samantha Cranko
609 779 5858
samantha.cranko@bioclinica.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/charles-bodner-joins-bioclinica-as-chief-operating--financial-officer-maureen-marchek-promoted-to-senior-vice-president-301010253.html
SOURCE Bioclinica
